Organization · Venture Studio
Ampleia
Ampleia is a venture-building organization focused on supporting projects in rare disease therapeutics. They collaborate with scientists and entrepreneurs to develop therapeutic options for underserved indications.
Overview
What Ampleia does
What Ampleia is
Ampleia is a venture-building organization focused on supporting projects in rare disease therapeutics. They collaborate with scientists and entrepreneurs to develop therapeutic options for underserved indications.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 11, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Ampleia elsewhere
Open the official website or a supported primary organization account.
Capability profile
Ampleia as a funder
Investment thesis
Ampleia focuses on addressing rare diseases through innovative solutions, aiming for high clinical benefits and financial returns by collaborating with leading research teams worldwide.
Focus narrative
Ampleia invests in the development of therapies for rare diseases, leveraging a network of over 6,000 medical and scientific experts. The organization emphasizes high pricing per patient and a higher likelihood of success in clinical trials for orphan drugs compared to non-orphan drugs.
Value beyond capital
Ampleia provides access to a vast network of medical and scientific experts, enhancing the likelihood of success in developing therapies for rare diseases.
Focus and fit
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 2
Portfolio context
Stealth Biotech: A first-in-class therapeutic targeting novel metabolite transport. Stealth Biotech: A gene-therapy platform for large payload delivery.
Capability profile
Ampleia as a program host
Program thesis
Ampleia is focused on addressing rare diseases through innovative solutions, aiming to build companies that deliver high clinical benefits and financial returns.
Focus narrative
Ampleia invests in the development of therapies for rare diseases, leveraging a network of over 6,000 medical and scientific experts. The organization highlights the potential for significant returns on investment in the rare disease sector, emphasizing high pricing per patient and a higher likelihood of success in clinical trials for orphan drugs compared to non-orphan drugs.
Value and support
Ampleia offers a robust network of medical and scientific experts, strategic collaboration opportunities, and a focus on high-impact therapies for rare diseases.
Availability
- Application state
- Not published
Focus and fit
- Stages
- Pre-seed · Seed
Alumni and track record
Alumni context
Notable portfolio companies include Stealth Biotech, which is developing a first-in-class therapeutic targeting novel metabolite transport and a gene-therapy platform for large payload delivery.
Common questions
What to know about Ampleia
Upseed classifies Ampleia under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 11, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.